Metavia announces $10.0 million private placement priced at-the-market under nasdaq rules

Cambridge, mass. , may 9, 2025 /prnewswire/ -- metavia inc. (nasdaq: mtva) ("metavia"), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced a private placement that metavia estimates will result in gross proceeds of approximately $10.0 million, before deducting the placement agent's fees and other offering expenses payable by the company.
NDAQ Ratings Summary
NDAQ Quant Ranking